The Belgium Financial Services and Markets Authority (FSMA) announced the suspension of trading in BIOTALYS financial instruments on Euronext Brussels at the company’s request, pending the publication of a company press release. The suspension covers BIOTALYS (ISIN BE0974386188) and applies from 9 February 2026 at 09:00 CET until the press release is published.